BioWorld Asia

Dec. 13, 2006

View Archived Issues

Blindness Gene Identified In Chickens Could Have Impact

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Belgium's ThromboGenics In Novel Biotech Deal With India

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Actelion Shares On Rise As Actelion-1 Now In Phase III

Peptech Ponders Various Ways Of Spending £71.3M

Genfit To List Shares On Alternext Market In Paris

PanGenetics In Deals With Schering-Plough, LayLine

Other News To Note

Newron Raises CHF118.12M In Swiss Initial Public Offering

Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International) Read More

Pharminox, Schering-Plough Enter Deal Worth Up To $40M

Today's news in brief

BioWorld

BioWorld briefs for July 20, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

Capital remains selective in ‘barbell’ biotech market

BioWorld

Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...

Silhouette of head and brainwith fractal art

ATAI-dyed Lilly tees up in psychedelics, finds $3.8B fit

BioWorld

Rumblings that psychedelic treatments would soon be ready for prime time gained credence aplenty, and shares of Ataibeckley Inc. (NASDAQ:ATAI) ended July 16 at...